ScinoPharm, Sundia MediTech Partner for Pharma Outsourcing in China - - BioPharm International

ADVERTISEMENT

ScinoPharm, Sundia MediTech Partner for Pharma Outsourcing in China



ScinoPharm Changshu Pharmaceuticals and Sundia MediTech have formed a strategic alliance to for contract research and manufacturing Services (CRAMS) in mainland China.

This cooperation combines Sundia’s capabilities in new drug R&D with ScinoPharm’s process R&D and commercial production expertise, especially in the field of highly potent oncological APIs.  Under the alliance, both parties will be able to further support customer needs with one-stop solutions for integrated services such as drug development, research, clinical trials, and commercial manufacturing. 

Sondia MediTech is a Shanhai-based CRO with a research team of 600 employees. ScinoPharm Changsho, located in the Jiangsu Province in China is a subsidiary of ScinoPharm Taiwan.

Source: ScinoPharm

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Author Guidelines

Click here